Survival of infantile fulminant hepatitis B and treatment with Lamivudine

J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):518-20. doi: 10.1097/01.mpg.0000144374.63230.44.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Hepatitis B / complications
  • Hepatitis B / drug therapy*
  • Hepatitis B Surface Antigens / drug effects
  • Hepatitis B Surface Antigens / metabolism
  • Hepatitis B virus / drug effects*
  • Humans
  • Infant
  • Lamivudine / therapeutic use*
  • Liver Failure / drug therapy*
  • Liver Failure / etiology
  • Male
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Hepatitis B Surface Antigens
  • Reverse Transcriptase Inhibitors
  • Lamivudine